Literature DB >> 35786623

Modeling the Trend Changes of Liver Cancer Mortality in the 6 WHO Regions.

Seyedeh Fatemeh Musavi Ezmareh1, Kamran Mehrabani2, Hadi Raeisi Shahraki3.   

Abstract

BACKGROUND: There is little information about comparison of the mortality patterns in different regions. The current study aimed to assess the trend changes of liver cancer mortality in 6 WHO regions.
METHODS: The mortality rates of liver cancer in the 6 WHO regions during 1990 to 2017 were extracted from the Global Burden of Disease database. Growth mixture model was used to identify the latent patterns using a set of tools to handle both the within and between trajectory variations. All the modeling procedures were implemented in Mplus 7.4 software.
RESULTS: The mortality rate in Africa showed a slow decreasing trend throughout the observation period, but a slow increase was observed in the Eastern Mediterranean region, European region, region of the Americas, and South-East Asia region. The slope of the rise in liver cancer mortality rate for Western Pacific region was 3-4 times higher than the other regions. 2-pattern growth mixture model was estimated as the best model. The Western Pacific region with annual increase of 0.20 in the liver cancer mortality rate was in the first pattern and the other 5 regions including Africa region, Eastern Mediterranean region, European region, region of the Americas, and South-East Asia region with annual increase of 0.05 in liver cancer mortality rate belonged to the second pattern.
CONCLUSION: Observed pattern in the Western Pacific region is not favorable. Taking into account a set of urgent prevention actions to control mortality rate of liver cancer in this region seems necessary.

Entities:  

Mesh:

Year:  2022        PMID: 35786623      PMCID: PMC9319567          DOI: 10.5152/tjg.2022.21363

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.555


  33 in total

Review 1.  Epidemiology of viral hepatitis and hepatocellular carcinoma.

Authors:  Hashem B El-Serag
Journal:  Gastroenterology       Date:  2012-05       Impact factor: 22.682

Review 2.  Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma.

Authors:  Lung-Yi Mak; Vania Cruz-Ramón; Paulina Chinchilla-López; Harrys A Torres; Noelle K LoConte; John P Rice; Lewis E Foxhall; Erich M Sturgis; Janette K Merrill; Howard H Bailey; Nahum Méndez-Sánchez; Man-Fung Yuen; Jessica P Hwang
Journal:  Am Soc Clin Oncol Educ Book       Date:  2018-05-23

3.  Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma.

Authors:  M C Kew; M Houghton; Q L Choo; G Kuo
Journal:  Lancet       Date:  1990-04-14       Impact factor: 79.321

4.  Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study.

Authors:  Rohit Loomba; Hwai-I Yang; Jun Su; David Brenner; Elizabeth Barrett-Connor; Uchenna Iloeje; Chien-Jen Chen
Journal:  Am J Epidemiol       Date:  2013-01-24       Impact factor: 4.897

5.  Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States.

Authors:  Sean F Altekruse; S Jane Henley; James E Cucinelli; Katherine A McGlynn
Journal:  Am J Gastroenterol       Date:  2014-02-11       Impact factor: 10.864

Review 6.  Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies.

Authors:  Laura Pimpin; Helena Cortez-Pinto; Francesco Negro; Emily Corbould; Jeffrey V Lazarus; Laura Webber; Nick Sheron
Journal:  J Hepatol       Date:  2018-05-17       Impact factor: 25.083

7.  Estimates and projections of hepatitis B-related hepatocellular carcinoma in Australia among people born in Asia-Pacific countries.

Authors:  Van Thi Thuy Nguyen; Karina Razali; Janaki Amin; Matthew G Law; Gregory J Dore
Journal:  J Gastroenterol Hepatol       Date:  2007-07-01       Impact factor: 4.029

Review 8.  Cancer burden and control in the Western Pacific region: challenges and opportunities.

Authors:  Cherian Varghese; Marie Clem Carlos; Hai-Rim Shin
Journal:  Ann Glob Health       Date:  2014 Sep-Oct       Impact factor: 2.462

Review 9.  Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, and Prevention.

Authors:  György Baffy
Journal:  J Clin Transl Hepatol       Date:  2013-12-15

10.  Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study.

Authors:  Elliot B Tapper; Neehar D Parikh
Journal:  BMJ       Date:  2018-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.